# Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.

> PubMed lists PMID 26732557 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2015-12-28 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26732557-ziconotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26732557-ziconotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-26732557-ziconotide-v1.json
- Content SHA-256: `be23e7acb3e5a0a8cd9b53289eb84bdcef44ddc2b09c29f78eda74808b484d5d`

## Claims and source pins

### Headline

Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain. ([`pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b`](#source-pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b))

### Summary

PubMed lists PMID 26732557 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2015-12-28 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b`](#source-pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b))

### Paragraph 1

PubMed lists PMID 26732557 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2015-12-28 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b`](#source-pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b`](#source-pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b))

## Sources

<a id="source-pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b"></a>
- **Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain. · retained source version 1:2018-11-13:current:e38554f2a45bcc25e071d89dec2071348e5d222085f9c974439faae3005e9c28** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26732557/) (`pubmed-observation-pmid-26732557-2018-11-13-e38554f2a45b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-26732557-ziconotide-v1.json SHA-256: be23e7acb3e5a0a8cd9b53289eb84bdcef44ddc2b09c29f78eda74808b484d5d.